Dexmedetomidine and Dexamethasone, Which is a better adjuvant with Ropivacaine in Adductor canal block?

Comparison of Dexmedetomidine and Dexamethasone as adjuvant to Ropivacaine in Ultrasound guided Adductor canal block , for postoperative analgesia in knee Arthroscopic surgeries. A Randomised double blind study. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058472

Enrollment

Registered

2023-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M239- Unspecified internal derangement of knee

Interventions

Intervention1: Adductor canal block: Ultrasound guided single shot adductor canal block with 20 ml of 0.375% Ropivacaine and adjuvants Control Intervention1: Dexmedetomidine and Dexamethasone.: Dexmed

Eligibility

Inclusion criteria

Inclusion criteria: Elective knee arthroscopic surgeries under sub arachinoid block, giving consent to postoperative adductor canal block. Age within 18 to 65, belonging to either gender. American society of anaesthesiologists grade I and II

Exclusion criteria

Exclusion criteria: Allergy to any of the drugs used. Any contraindication to adductor canal block and Sub Arachinoid Block, like local infection. History of diseases like diabetic neuropathy or any other neuropathy. Any liver dysfunction or renal dysfunction. Body mass index more than 35. Patients who are on any anticoagulants or sedatives or having any deranged coagulation profile. Pregnant females. Patients with partial Sub Arachinoid Block, in need of additional analgesia during surgery.

Design outcomes

Primary

Measure	Time frame
Comparison of total analgesia duration.Timepoint: Total requirement of rescue analgesia over a period of 24 hours.	—

Secondary

Measure	Time frame
PATIENT SATISFACTION SCORE EARLY TOE MOBILITY HEMODYNAMIC STABILITY SIDE EFFECTS, IF ANYTimepoint: 24 HOURS	—

Countries

India

Contacts

Public ContactMuhsina K

BLK Super Speciality Hospital

chetansaraya@hotmail.com9539888198

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026